Abstract
Hereditary breast and ovarian cancer syndrome (HBOC) is a cancer predisposition syndrome that affects both men and women, with more significant cancer risk elevations in women. Dissemination patterns regarding familial genetic risk information among females with HBOC are fairly well defined, but knowledge about how males share this information is limited. We interviewed 21 people primarily Ashkenazi Jewish men who were accrued via listserv email through Facing Our Risk of Cancer Empowered (FORCE). Interviews focused on family cancer history, experiences with cancer and genetic testing, motivations to pursue genetic testing and subsequently disclose genetic test results, information-sharing patterns, health care provider response, and participants’ emotional support systems. The interviews were transcribed in their entirety, coded, and analyzed based on recurring themes. Eighteen transcripts were used for the analysis. Results were classified into five main themes. Participants (n = 8) were most concerned about cancer risk for their children and female family members, and most (n = 11) mentioned that HBOC provides them increased personal awareness, but has a negligible impact on their life overall (n = 9). Men (n = 11) were interested in a male-focused support group to discuss HBOC and gain knowledge and information. Participants (n = 9) took on active and open communication roles with family members and health care providers. The majority of participants (n = 14) discussed the need for knowledge and awareness among the health care community and general population regarding male HBOC risks. This study serves as a pilot study and provides important and novel insights into psychosocial impacts, communication patterns, encounters with health care professionals, and expressed needs of males with HBOC.
Similar content being viewed by others
References
d’Agincourt-Canning, L. (2001). Experiences of genetic risk: disclosure and the gendering of responsibility. Bioethics, 15(3), 231–247.
Antoniou, A., Pharoah, P. D., Narod, S., Risch, H. A., Eyfjord, J. E., Hopper, J. L., Loman, N., Olsson, H., Johannsson, O., Borg, A., Pasini, B., Radice, P., Manoukian, S., Eccles, D. M., Tang, N., Olah, E., Anton-Culver, H., Warner, E., Lubinski, J., Gronwald, J., Gorski, B., Tulinius, H., Thorlacius, S., Eerola, H., Nevanlinna, H., Syrjakoski, K., Kallioniemi, O. P., Thompson, D., Evans, C., Peto, J., Lalloo, F., Evans, D. G., & Easton, D. F. (2003). Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case series unselected for family history: a combined analysis of 22 studies. American Journal of Human Genetics, 72(5), 1117–1130.
Braun, V., & Clarke, V. (2006). Using thematic analysis in psychology. Qualitative Research in Psychology, 3(2), 77–101.
Cheng, H. H., Pritchard, C. C., Montgomery, B., Lin, D. W., & Nelson, P. S. (2017). Prostate cancer screening in a new era of genetics. Clinical Genitourinary Cancer, 15(6), 625–628.
Cheung, E. L., Olson, A. D., Yu, T. M., Han, P. Z., & Beattie, M. S. (2010). Communication of BRCA results and family testing in 1,103 high-risk women. Cancer Epidemiology, Biomarkers, & Prevention: A Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology, 19(9), 2211–2219.
Dancyger, C., Wiseman, M., Jacobs, C., Smith, J. A., Wallace, M., & Michie, S. (2011). Communicating BRCA1/2 genetic test results within the family: a qualitative analysis. Psychology & Health, 26(8), 1018–1035.
Finlay, E., Stopfer, J. E., Burlingame, E., Evans, K. G., Nathanson, K. L., Weber, B. L., Armstrong, K., Rebbeck, T. R., & Domchek, S. M. (2008). Factors determining dissemination of results and uptake of genetic testing in families with known BRCA1/2 mutations. Genetic Testing, 12(1), 81–91.
Gadzicki, D., Wingen, L. U., Teige, B., Horn, D., Bosse, K., Kreuz, F., Goecke, T., Schafer, D., Voigtlander, T., Fischer, B., Froster, U., Welling, B., Debatin, I., Weber, B. H., Schonbuchner, I., Nippert, I., Schlegelberger, B., & German Cancer Aid Consortium on Hereditary Breast and Ovarian Cancer. (2006). Communicating BRCA1 and BRCA2 genetic test results. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 24(18), 2969–2970 author reply 2970-1.
Graves, K. D., Gatammah, R., Peshkin, B. N., Krieger, A., Gell, C., Valdimarsdottir, H. B., & Schwartz, M. D. (2011). BRCA1/2 genetic testing uptake and psychosocial outcomes in men. Familial Cancer, 10(2), 213–223.
Hallowell, N., Ardern-Jones, A., Eeles, R., Foster, C., Lucassen, A., Moynihan, C., & Watson, M. (2005). Communication about genetic testing in families of male BRCA1/2 carriers and non-carriers: patterns, priorities and problems. Clinical Genetics, 67(6), 492–502.
Liede, A., Metcalfe, K., Hanna, D., Hoodfar, E., Snyder, C., Durham, C., Lynch, H. T., & Narod, S. A. (2000). Evaluation of the needs of male carriers of mutations in BRCA1 or BRCA2 who have undergone genetic counseling. American Journal of Human Genetics, 67(6), 1494–1504.
Liede, A., Karlan, B. Y., & Narod, S. A. (2004). Cancer risks for male carriers of germline mutations in BRCA1 or BRCA2: a review of the literature. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 22(4), 735–742.
Ormond, K. E., Mills, P. L., Lester, L. A., & Ross, L. F. (2003). Effect of family history on disclosure patterns of cystic fibrosis carrier status. American Journal of Medical Genetics, Part C, Seminars in Medical Genetics, 119C(1), 70–77.
Patenaude, A. F., Dorval, M., DiGianni, L. S., Schneider, K. A., Chittenden, A., & Garber, J. E. (2006). Sharing BRCA1/2 test results with first-degree relatives: factors predicting who women tell. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology, 24(4), 700–706.
Peterson, S. K., Watts, B. G., Koehly, L. M., Vernon, S. W., Baile, W. F., Kohlmann, W. K., & Gritz, E. R. (2003). How families communicate about HNPCC genetic testing: Findings from a qualitative study. American Journal of Medical Genetics. Part C, Seminars in Medical Genetics, 119C(1), 78–86.
Shiloh, S., Dagan, E., Friedman, I., Blank, N., & Friedman, E. (2013). A follow-up study on men tested for BRCA1/BRCA2 mutations: impacts and coping processes. Psycho-Oncology, 22(2), 417–425.
Stromsvik, N., Raheim, M., Oyen, N., & Gjengedal, E. (2009). Men in the women’s world of hereditary breast and ovarian cancer—a systematic review. Familial Cancer, 8(3), 221–229.
Stromsvik, N., Raheim, M., & Gjengedal, E. (2011). Cancer worry among Norwegian male BRCA1/2 mutation carriers. Familial Cancer, 10(3), 597–603.
Vadaparampil, S. T., Malo, T., de la Cruz, C., & Christie, J. (2012). Do breast cancer patients tested in the oncology care setting share BRCA mutation results with family members and health care providers? Journal of Cancer Epidemiology, 2012, 498062.
Wiseman, M., Dancyger, C., & Michie, S. (2010). Communicating genetic risk information within families: a review. Familial Cancer, 9(4), 691–703.
Wymer, P. (1996). The troubled helix: social and psychological implications of the new human genetics. In T. Marteau & M. Richards (Eds.), Cambridge University Press. Trends in Biochemical Sciences, 21(10), 404.
Acknowledgments
This work was possible thanks to Sue Freidman and Facing our Risk of Cancer Empowered (FORCE) and Kami Wolfe-Schneider as a manuscript reviewer and with expert qualitative analysis support by Shelly Hovick, PhD, of The Ohio State University. This work was conducted to fulfill a degree requirement at The Ohio State University.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of Interest
Alexandra Suttman, MS; Robert Pilarski, MS, MSW; Doreen M. Agnese, MD; and Leigha Senter, MS declare that they have no conflict of interest.
Human Studies and Informed Consent
All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2000(5). Informed consent was obtained from all patients for being included in this study.
Additional informed consent was obtained from all patients for which identifying information is included in this article.
Animal Studies
No animal studies were carried out by the authors for this article.
Rights and permissions
About this article
Cite this article
Suttman, A., Pilarski, R., Agnese, D.M. et al. “Second-Class Status?” Insight into Communication Patterns and Common Concerns Among Men with Hereditary Breast and Ovarian Cancer Syndrome. J Genet Counsel 27, 885–893 (2018). https://doi.org/10.1007/s10897-018-0214-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10897-018-0214-z